| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |